218 related articles for article (PubMed ID: 30610160)
1.
Liu P; Zhuo Z; Li W; Cheng J; Zhou H; He J; Zhang J; Wang J
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610160
[TBL] [Abstract][Full Text] [Related]
2. The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children.
Wang J; Lou S; Huang X; Mo Y; Wang Z; Zhu J; Tian X; Shi J; Zhou H; He J; Ruan J
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32083300
[TBL] [Abstract][Full Text] [Related]
3. Association of
Liao F; Yuan L; Zhu J; Chen W; Zhao Y; He J
Biomed Res Int; 2022; 2022():2712808. PubMed ID: 35996546
[TBL] [Abstract][Full Text] [Related]
4. The
He J; Wang F; Zhu J; Zhang Z; Zou Y; Zhang R; Yang T; Xia H
Aging (Albany NY); 2017 Mar; 9(3):852-859. PubMed ID: 28275206
[No Abstract] [Full Text] [Related]
5. Association between
Fu W; Zhuo ZJ; Jia W; Zhu J; Zhu SB; Lin ZF; Wang FH; Xia H; He J; Liu GC
Onco Targets Ther; 2017; 10():1149-1154. PubMed ID: 28260929
[TBL] [Abstract][Full Text] [Related]
6. TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case-control study.
Fang Y; Wu X; Li L; Zhu J; Wu H; Zhou H; He J; Wang Y
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406493
[TBL] [Abstract][Full Text] [Related]
7. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
[TBL] [Abstract][Full Text] [Related]
8. Association of the
Yang T; Wen Y; Li J; Yang J; Tan T; Pan J; Hu C; Zhang J; Xin Y; Li S; Xia H; He J; Zou Y
J Cancer; 2019; 10(15):3444-3449. PubMed ID: 31293648
[TBL] [Abstract][Full Text] [Related]
9. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
Sun Z; Gao W; Cui JT
BMC Oral Health; 2018 Aug; 18(1):143. PubMed ID: 30126398
[TBL] [Abstract][Full Text] [Related]
10. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
Huang X; Wu F; Zhang Z; Shao Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
[No Abstract] [Full Text] [Related]
11. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
[TBL] [Abstract][Full Text] [Related]
12. TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population.
Yang J; Wu X; Huang J; Chen Z; Huang G; Guo X; Zhu L; Su L
J Mol Neurosci; 2019 Aug; 68(4):679-687. PubMed ID: 31055723
[TBL] [Abstract][Full Text] [Related]
13. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
14. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.
Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; Guimarães AL
Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726
[TBL] [Abstract][Full Text] [Related]
15. Association of TP53 rs1042522 with cervical cancer in the sub-Saharan African population: a meta-analysis.
Kamiza AB; Kamiza S; Singini MG; Mathew CG
Trop Med Int Health; 2020 Jun; 25(6):666-672. PubMed ID: 32233050
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers.
Salemi M; Barone C; Salluzzo MG; Giambirtone M; Scillato F; Galati Rando R; Romano C; Morale MC; Ridolfo F; Romano C
J Matern Fetal Neonatal Med; 2017 Nov; 30(22):2752-2754. PubMed ID: 27852141
[TBL] [Abstract][Full Text] [Related]
17. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
[TBL] [Abstract][Full Text] [Related]
18. MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients.
Wang X; Wang YZ; Ma KW; Chen X; Li W
Oncol Res Treat; 2014; 37(4):176-80. PubMed ID: 24732641
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
[TBL] [Abstract][Full Text] [Related]
20. Association Between Arg72Pro Polymorphism in
Liu Z; Xiao Z; Li M; Xiao Y; Wang X; He J; Li Y
Cancer Control; 2021; 28():10732748211004880. PubMed ID: 33759598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
